Emerging technologies for cancer therapy using accelerated particles

C Graeff, L Volz, M Durante - Progress in particle and nuclear physics, 2023 - Elsevier
Cancer therapy with accelerated charged particles is one of the most valuable biomedical
applications of nuclear physics. The technology has vastly evolved in the past 50 years, the …

The anatomic basis of leptomeningeal metastasis

ME Freret, A Boire - Journal of Experimental Medicine, 2024 - rupress.org
Leptomeningeal metastasis (LM), or spread of cancer to the cerebrospinal fluid (CSF)–filled
space surrounding the central nervous system, is a fatal complication of cancer. Entry into …

[HTML][HTML] 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)

F Cardoso, S Paluch-Shimon, E Schumacher-Wulf… - The breast, 2024 - Elsevier
This manuscript describes the Advanced Breast Cancer (ABC) international consensus
guidelines updated at the last two ABC international consensus conferences (ABC 6 in …

Hypothyroidism following radiotherapy for head and neck cancer: a systematic review of the literature and opportunities to improve the therapeutic ratio

MK Rooney, LM Andring, KL Corrigan, V Bernard… - Cancers, 2023 - mdpi.com
Simple Summary Hypothyroidism is a common toxicity experienced after radiotherapy for
head and neck malignancies. In this systemic review of the literature, we consolidated the …

Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases

AM Lazaratos, SM Maritan, A Quaiattini, A Darlix… - The Breast, 2023 - Elsevier
Background Patients with HER2+ breast cancer (BC) frequently develop leptomeningeal
metastases (LM). While HER2-targeted therapies have demonstrated efficacy in the …

Leptomeningeal metastases in melanoma patients: an update on and future perspectives for diagnosis and treatment

J Steininger, FF Gellrich, K Engellandt… - International journal of …, 2023 - mdpi.com
Leptomeningeal disease (LMD) is a devastating complication of cancer with a particularly
poor prognosis. Among solid tumours, malignant melanoma (MM) has one of the highest …

Systemic therapy for melanoma brain and leptomeningeal metastases

WJ Sherman, E Romiti, L Michaelides… - … treatment options in …, 2023 - Springer
Opinion statement Melanoma has a high propensity to metastasize to the brain which
portends a poorer prognosis. With advanced radiation techniques and targeted therapies …

Pharmacotherapy for leptomeningeal disease in breast cancer

R Bartsch, KJ Jerzak, L Larrouquere, V Müller… - Cancer Treatment …, 2023 - Elsevier
Clinical data supporting the best therapeutic approach in leptomeningeal disease (LMD;
also known as leptomeningeal metastases or leptomeningeal carcinomatosis) are lacking …

Leptomeningeal disease (LMD) in patients with melanoma metastases

ML Khaled, AA Tarhini, PA Forsyth, I Smalley, Y Piña - Cancers, 2023 - mdpi.com
Simple Summary Leptomeningeal disease in melanoma (LMM) patients is characterized by
aggressiveness and dismal outcomes. Clinical studies and case reports demonstrate the …

The Spectrum of Headache in Leptomeningeal Metastases: A Comprehensive Review with Clinical Management Guidelines

JA Wilcox, R Estrera, A Boire - Current Pain and Headache Reports, 2023 - Springer
Abstract Purpose of Review Headaches are a common, oftentimes debilitating symptom in
patients with leptomeningeal metastases. Recent Findings The third edition of the …